CellResearch Unveils Clinical Data for Stem Cell Hair Restoration

Independent testing conducted in 2026 demonstrates that PTT-6, a secretome derived from umbilical cord lining stem cells, increases hair breakage resistance by 43%. Laboratory analysis of bleached human hair showed that the complex enhances the physical energy required to fracture a fiber, offering a protective buffer against daily heat styling and chemical treatments. Beyond fiber integrity, human trials revealed a 14% reduction in scalp redness after 28 days of use, with participants reporting a significant decrease in irritation and sensitivity.

These metrics support the broader clinical utility of the complex, which has already shown a 94% response rate for hair regrowth across eight international trials. By addressing follicle health, scalp inflammation, and structural tensile strength simultaneously, the technology targets the core drivers of hair loss. With the global hair and scalp care market projected to reach 150.5 billion dollars by 2033, CellResearch is positioning its professional-grade formula as a science-backed alternative to conventional cosmetic treatments. The company currently distributes its products through 7,000 clinic and salon partners across 40 markets, with plans to expand its retail footprint in North America.